Vaidyanathan G, Affleck D, Zalutsky M R
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
Nucl Med Biol. 1994 Jan;21(1):105-10. doi: 10.1016/0969-8051(94)90136-8.
N-Succinimidyl 3-[211At]astato-2, 4-dimethoxybenzoate (SADMB) was prepared from a trialkylstannyl precursor in about 70-75% yield. With either trimethyl or tri-n-butylstannyl precursor, no temporal effect was found in the astatodestannylation yield. However, the methyl analog gave slightly better yield which was found to be not statistically significant. A monoclonal antibody (MAb) fragment, Mel-14 F(ab')2, could be labeled using SADMB in 28% coupling efficiency. The specific binding of this labeled fragment to tumor homogenates in vitro was 61.0 +/- 0.5% (62.8 +/- 0.9% for the 131I labeled fragment). Paired-label tissue distribution in normal mice showed similar uptake of 131I and 211 At in many tissues. However, by 14.5 h selectivity of spleen, lungs and stomach for Mel-14 F(ab')2 labeled with 211At compared to 131I was 4.1, 3.8 and 6.4, respectively.
N-琥珀酰亚胺基3-[211At]砹代-2,4-二甲氧基苯甲酸酯(SADMB)由三烷基锡前体制备,产率约为70-75%。使用三甲基或三正丁基锡前体时,砹脱锡产率均未发现时间效应。然而,甲基类似物的产率略高,但差异无统计学意义。单克隆抗体(MAb)片段Mel-14 F(ab')2可用SADMB标记,偶联效率为28%。该标记片段与肿瘤匀浆的体外特异性结合率为61.0±0.5%(131I标记片段为62.8±0.9%)。正常小鼠的配对标记组织分布显示,许多组织中131I和211At的摄取相似。然而,到14.5小时时,与131I相比,211At标记的Mel-14 F(ab')2在脾脏、肺和胃中的选择性分别为4.1、3.8和6.4。